Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-24-005480

CEO, CFO, Director acquired 6,642 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Finley John David CEO, CFO, Director 2024-02-06 Option exercise +3,475 88,124 D
Finley John David CEO, CFO, Director 2024-02-06 Option exercise +3,167 91,291 D
Derivatives
Finley John David CEO, CFO, Director 2024-02-06 Option exercise · Restricted Stock Units −3,475 27,800 D
Finley John David CEO, CFO, Director 2024-02-06 Option exercise · Restricted Stock Units −3,167 34,833 D
Loading xslF345X05/ownership.xml…